Ben Ponvilawan

841 total citations
75 papers, 445 citations indexed

About

Ben Ponvilawan is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Ben Ponvilawan has authored 75 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 14 papers in Hematology. Recurrent topics in Ben Ponvilawan's work include Acute Myeloid Leukemia Research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ben Ponvilawan is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ben Ponvilawan collaborates with scholars based in United States, Thailand and Germany. Ben Ponvilawan's co-authors include Nipith Charoenngam, Patompong Ungprasert, Thanitsara Rittiphairoj, Aunchalee Jaroenlapnopparat, Phuuwadith Wattanachayakul, Weerapat Owattanapanich, Janakiraman Subramanian, Claudie Roy, Florian Kuchenbauer and Abdul Wali Khan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ben Ponvilawan

61 papers receiving 438 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ben Ponvilawan 80 78 73 71 70 75 445
Imane Azzaoui 100 1.3× 108 1.4× 182 2.5× 108 1.5× 69 1.0× 20 726
Bożena Targońska‐Stępniak 85 1.1× 126 1.6× 65 0.9× 50 0.7× 51 0.7× 41 490
Akinori Maeda 77 1.0× 56 0.7× 105 1.4× 33 0.5× 43 0.6× 48 539
Ramazan Güneşaçar 159 2.0× 71 0.9× 51 0.7× 26 0.4× 57 0.8× 34 460
Kumiko Shimoyama 56 0.7× 45 0.6× 72 1.0× 85 1.2× 62 0.9× 30 342
Anna Olewicz‐Gawlik 56 0.7× 35 0.4× 40 0.5× 108 1.5× 52 0.7× 31 338
Е Н Александрова 90 1.1× 66 0.8× 60 0.8× 88 1.2× 106 1.5× 210 610
Jumpei Temmoku 133 1.7× 81 1.0× 70 1.0× 28 0.4× 43 0.6× 67 453
S. Marzouk 129 1.6× 53 0.7× 40 0.5× 76 1.1× 61 0.9× 94 652
Noemi Ron 97 1.2× 48 0.6× 85 1.2× 73 1.0× 35 0.5× 19 400

Countries citing papers authored by Ben Ponvilawan

Since Specialization
Citations

This map shows the geographic impact of Ben Ponvilawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Ponvilawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Ponvilawan more than expected).

Fields of papers citing papers by Ben Ponvilawan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Ponvilawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Ponvilawan. The network helps show where Ben Ponvilawan may publish in the future.

Co-authorship network of co-authors of Ben Ponvilawan

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Ponvilawan. A scholar is included among the top collaborators of Ben Ponvilawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Ponvilawan. Ben Ponvilawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ponvilawan, Ben, et al.. (2025). Long-Term Survival by Number of Immune Checkpoint Inhibitors in PD-L1–Negative Metastatic NSCLC. JAMA Network Open. 8(2). e2457357–e2457357. 1 indexed citations
2.
Ponvilawan, Ben, et al.. (2025). Prevalence of genetic alterations in basal cell carcinoma patients resistant to Hedgehog pathway inhibitors: a systematic review. Annals of Medicine. 57(1). 2516701–2516701. 1 indexed citations
3.
Ponvilawan, Ben, Phuwanat Sakornsakolpat, Ananya Pongpaibul, et al.. (2025). Comprehensive genomic analysis in sporadic early-onset colorectal adenocarcinoma patients. BMC Cancer. 25(1). 349–349. 1 indexed citations
4.
5.
Khan, Abdul Wali, et al.. (2025). Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series. Exploration of Targeted Anti-tumor Therapy. 6. 1002347–1002347.
6.
Ponvilawan, Ben, et al.. (2025). A review on disease modifying pharmacologic therapies for sickle cell disease. Annals of Hematology. 104(2). 881–893. 4 indexed citations
7.
Ponvilawan, Ben, et al.. (2024). Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors. Cancers. 16(6). 1225–1225. 11 indexed citations
8.
Ponvilawan, Ben, et al.. (2024). Incidence and Outcomes of Post-Transplant Erythrocytosis in Kidney Transplant Recipients: A Cohort Study in a Southeast Asian Country. Blood. 144(Supplement 1). 5211–5211. 1 indexed citations
9.
Danpanichkul, Pojsakorn, Ben Ponvilawan, Daniel Martin Simadibrata, et al.. (2024). Global epidemiology of early‐onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019. Journal of Gastroenterology and Hepatology. 39(9). 1856–1868. 14 indexed citations
10.
Ponvilawan, Ben, et al.. (2024). A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review. Clinical Lung Cancer. 25(5). 479–482. 3 indexed citations
11.
12.
Shahzad, Moazzam, Ben Ponvilawan, Muhammad Kashif Amin, et al.. (2024). Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review. Blood. 144(Supplement 1). 7237–7237.
13.
Mori, Minako, Yasuo Kubota, Arda Durmaz, et al.. (2023). Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. Leukemia. 37(10). 2082–2093. 10 indexed citations
14.
Charoenngam, Nipith, et al.. (2023). Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review. International Journal of Endocrinology. 2023. 1–9. 2 indexed citations
15.
Charoenngam, Nipith, et al.. (2023). THU613 Multiple Endocrine Neoplasia Type 5 Associated With Germline Max Mutations—New Insights Into This Proposed Entity. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
16.
Durmaz, Arda, Carmelo Gurnari, Courtney E. Hershberger, et al.. (2023). A multimodal analysis of genomic and RNA splicing features in myeloid malignancies. iScience. 26(3). 106238–106238. 3 indexed citations
17.
Bahaj, Waled, Tariq Kewan, Carmelo Gurnari, et al.. (2023). Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia. Journal of Hematology & Oncology. 16(1). 91–91. 14 indexed citations
18.
19.
Jaroenlapnopparat, Aunchalee, et al.. (2022). Vitamin D-related Genetic Variations and Non-alcoholic Fatty Liver Disease: a Systematic Review. Preprints.org. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imane Azzaoui Breakdown of academic impact, for papers by Bożena Targońska‐Stępniak Breakdown of academic impact, for papers by Akinori Maeda Breakdown of academic impact, for papers by Ramazan Güneşaçar Breakdown of academic impact, for papers by Kumiko Shimoyama Breakdown of academic impact, for papers by Anna Olewicz‐Gawlik Breakdown of academic impact, for papers by Е Н Александрова Breakdown of academic impact, for papers by Jumpei Temmoku Breakdown of academic impact, for papers by S. Marzouk Breakdown of academic impact, for papers by Noemi Ron
Rankless by CCL
2026